Radiotherapy toxicity management
Revision as of 22:55, 14 August 2023 by Warner-admin (talk | contribs) (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
| Focus editor | Associate editor | ||
|---|---|---|---|
 |
Michael K. Rooney, MD MD Anderson Cancer Center Houston, TX, USA |
 |
Danielle S. Bitterman, MD Dana-Farber Cancer Institute Boston, MA, USA |
The purpose of this page is to address the management of toxicity from radiation therapy.
To be created!